HopeStage
Back to all studies
CompletedNCT04554121

Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing

Behavioural studyAges 18–68United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 68 years.

Listed locations
Stamford, United States · Brooklyn, United States and 3 more locationsSee all locations and recruitment
Activities
Behavioural activities described in the protocol
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: December 14, 2020
Recruitment status
Completed
Enrollment listed in the registry
194
Sponsor
Columbia University
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 68 Years
Official registry ID
NCT04554121
Official title
Show the full official title

Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stamford · Brooklyn · New York

2 more locations
  • Orangeburg
  • The Bronx
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Columbia University, a university.

Who was this study for?

Listed age limits: 18 years to 68 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me